We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LMNR:NASDAQLimoneira Co Analysis

Data as of 2026-05-19 - not real-time

$13.21

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Limoneira Company (LMNR) is trading near its recent support at $12.38 with a 20‑day SMA of $12.88, still below the 50‑day SMA ($13.14) and the 200‑day SMA ($14.15), signaling a bearish price structure. The RSI sits at 54.6, indicating neutral momentum, while the MACD histogram is positive (+0.065) and the signal line is bearish, suggesting a tentative short‑term upside that conflicts with the overall bearish trend direction. Volatility remains high at 24.6% over the past 30 days, but beta is modest at 0.74, reflecting limited sensitivity to market moves. Fundamentally, the company posted a 46.9% revenue decline, negative gross (‑3.2%) and operating margins (‑57.6%), and a trailing EPS of –$1.28, yet it maintains a 2.21% dividend yield with a payout ratio near 70%, raising concerns about sustainability given negative operating cash flow and a $91.9 M debt load. The recent earnings call highlighted a “strategic transformation” and a return to key lemon sales channels, which could lay groundwork for a longer‑term turnaround, but the current cash position ($1.27 M) is insufficient to offset the debt burden. While the forward P/E of 23.6 and price‑to‑book of 1.59 appear reasonable, the negative cash generation and high leverage suggest the stock may be overvalued relative to its underlying earnings potential. Investors should weigh the modest dividend income against the sizable operational challenges and the uncertain timeline for the announced strategic initiatives.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish bias
  • Negative earnings and high debt increase downside risk
  • High 30‑day volatility amplifies short‑term price swings

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strategic transformation announced in earnings call
  • Dividend yield provides modest income cushion
  • Continued cash‑flow deficits and leverage limit upside

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Potential upside from real‑estate and land‑lease assets
  • Improved operational efficiency could restore margins
  • Current price‑to‑book suggests room for valuation improvement if turnaround succeeds

Key Metrics & Analysis

Financial Health

Revenue Growth-46.90%
Profit Margin-15.55%
P/E Ratio23.6
ROE-11.96%
ROA-5.59%
Debt/Equity50.86
P/B Ratio1.6
Op. Cash Flow$-4836000
Free Cash Flow$-17812750

Technical Analysis

TrendBearish
RSI54.6
Support$12.38
Resistance$13.88
MA 20$12.88
MA 50$13.14
MA 200$14.15
MACDBullish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Target Price$22.33
Upside/Downside69.06%
GradeOvervalued
TypeValue
Dividend Yield2.21%

Risk Assessment

Beta0.74
Volatility24.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.